These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7783818)

  • 1. [Cladribine in chronic progressive multiple sclerosis].
    Weilbach FX; Hartung HP
    Nervenarzt; 1995 Apr; 66(4):299-303. PubMed ID: 7783818
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of multiple sclerosis and other autoimmune diseases with cladribine.
    Beutler E; Sipe J; Romine J; McMillan R; Zyroff J; Koziol J
    Semin Hematol; 1996 Jan; 33(1 Suppl 1):45-52. PubMed ID: 8714617
    [No Abstract]   [Full Text] [Related]  

  • 3. [Interferon-beta in treatment of relapsing multiple sclerosis].
    Hartung HP; Hohlfeld R
    Nervenarzt; 1994 Feb; 65(2):139-45. PubMed ID: 8164769
    [No Abstract]   [Full Text] [Related]  

  • 4. [Oral, low-dosage methotrexate in chronic progressive multiple sclerosis. A preliminary critical analysis].
    Weilbach FX; Toyka KV; Hartung HP
    Nervenarzt; 1995 Aug; 66(8):643-7. PubMed ID: 7566279
    [No Abstract]   [Full Text] [Related]  

  • 5. Histological examination of the lacrimal gland after experimental administration of Cladribine.
    Kwietniewska M; Czerny K
    Ann Univ Mariae Curie Sklodowska Med; 2002; 57(2):526-30. PubMed ID: 12898890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of cladribine treatment in multiple sclerosis.
    Sipe JC; Romine JS; Koziol JA; McMillan R; Zyroff J; Beutler E
    Mult Scler; 1996 Jul; 1(6):343-7. PubMed ID: 9345414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Current therapy of multiple sclerosis: mitoxantrone].
    Spuler S; Hohlfeld R
    Nervenarzt; 1994 Feb; 65(2):136-8. PubMed ID: 8164768
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of repeated treatments with cladribine (2-chlorodeoxyadenosine) on blood counts in multiple sclerosis patients.
    Grieb P; Stelmasiak Z; Solski J; Nowicki J; Jakubowska B; Ryba M
    Arch Immunol Ther Exp (Warsz); 1995; 43(5-6):323-7. PubMed ID: 8744654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Marrow suppression produced by repeated doses of cladribine.
    Beutler E; Koziol JA; McMillan R; Sipe JC; Romine JS; Carrera CJ
    Acta Haematol; 1994; 91(1):10-5. PubMed ID: 8171930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Guidelines for drug treatment of multiple sclerosis].
    Kollegger H; Vass K; Marschall I; Koch G; Deecke L
    Wien Klin Wochenschr; 1993; 105(16):443-52. PubMed ID: 7692677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histological examination of the extrabulbar segment of the optic nerve in experimental animals after administration of Cladribine.
    Kwietniewska M; Stelmasiak Z; Sekita-Krzak J; Visconti J; Czerny K
    Ann Univ Mariae Curie Sklodowska Med; 2002; 57(2):222-6. PubMed ID: 12898843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histological examination of the retinal ganglion layer in rabbits after experimental administration of the new immunosuppressive medicine--Cladribine.
    Kwietniewska M; Cybulska R; Kwietniewski P; Sekita-Krzak J; Czerny K
    Ann Univ Mariae Curie Sklodowska Med; 2002; 57(2):376-80. PubMed ID: 12898865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cladribine in treatment of chronic progressive multiple sclerosis.
    Sipe JC; Romine JS; Koziol JA; McMillan R; Zyroff J; Beutler E
    Lancet; 1994 Jul; 344(8914):9-13. PubMed ID: 7912347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Update: treatment of multiple sclerosis].
    Kümpfel T; Hohlfeld R
    MMW Fortschr Med; 2009 Mar; 151(13):70-2. PubMed ID: 19504824
    [No Abstract]   [Full Text] [Related]  

  • 15. The treatment of chronic progressive multiple sclerosis with cladribine.
    Beutler E; Sipe JC; Romine JS; Koziol JA; McMillan R; Zyroff J
    Proc Natl Acad Sci U S A; 1996 Feb; 93(4):1716-20. PubMed ID: 8643695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Interferon beta-1b in multiple sclerosis--news regarding open questions].
    Nervenarzt; 1997 Aug; 68(8 Suppl Interferon):1-4. PubMed ID: 9380220
    [No Abstract]   [Full Text] [Related]  

  • 17. HLA class II and response to interferon-beta in multiple sclerosis.
    Fernández O; Fernández V; Mayorga C; Guerrero M; León A; Tamayo JA; Alonso A; Romero F; Leyva L; Alonso A; Luque G; de Ramón E
    Acta Neurol Scand; 2005 Dec; 112(6):391-4. PubMed ID: 16281922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Superior clinical efficacy of Sinement CR 50/200 versus Sinemet 25/100 in patients with fluctuating Parkinson's disease. An open and a double-blind, double-dummy, multicenter treatment evaluation. Dutch Sinement CR Study Group.
    Wolters EC; Horstink MW; Roos RA; Jansen EN
    Adv Neurol; 1993; 60():648-52. PubMed ID: 8420204
    [No Abstract]   [Full Text] [Related]  

  • 19. Cladribine: an investigational immunomodulatory agent for multiple sclerosis.
    Brousil JA; Roberts RJ; Schlein AL
    Ann Pharmacother; 2006 Oct; 40(10):1814-21. PubMed ID: 16985095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of the new medicine--2-CDA (Cladribine) on the ultrastructure of the extrabulbar segment of the optic nerve in rabbits of New Zealand breed.
    Kwietniewska M; Stelmasiak Z; Sekita-Krzak J; Visconti J; Czerny K
    Ann Univ Mariae Curie Sklodowska Med; 2002; 57(2):227-32. PubMed ID: 12898844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.